Skip to Content

150 Logo 4357 (Ranitidine Hydrochloride 150 mg)

Pill with imprint 150 Logo 4357 is Beige, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.

Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 150 Logo 4357

Ranitidine hydrochloride 150 mg 150 Logo 4357
Ranitidine hydrochloride 150 mg 150 Logo 4357
Ranitidine hydrochloride 150 mg 150 Logo 4357

Ranitidine Hydrochloride

Imprint
150 Logo 4357
Strength
150 mg
Color
Beige
Size
9.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00172-4357
Inactive Ingredients
croscarmellose sodium, hypromelloses, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide red, titanium dioxide, triethyl citrate, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.